Pfizer cues up vitiligo filing for Litfulo after phase 3 win pharmaphorum 5d Litfulo Pharma All sources
Poland appeals Brussels ruling in Pfizer vaccine dispute TheNews.pl 20h Pfizer Vaccine Poland Eastern Europe All sources
Is Wall Street bullish or bearish on Pfizer stock? Barchart 7d Pfizer Vaccine Wall Street Stock Market (US) All sources
Cafc affirms ptab denial of motions to amend remaining Pfizer claims invalidated by Sanofi IPWatchdog.com 2d Sanofi Patent Law Intellectual Property
Romanian air traffic operator Romatsa gets January 2027 hearing in Pfizer revenue freeze case Romania Insider 6d Pfizer Romania Pharma All sources
Sanofi sues Moderna, Pfizer for vaccine-Tech patent royalties Bloomberg Law 16:00 Wed, 15 Jul All sources
Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Benzinga 2h Article paywall
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield? The Motley Fool 13h
FTSE 100 movers: AstraZeneca tumbles on merger report; housebuilders rally ShareCast 17h FTSE 100 AstraZeneca Mergers and Acquisitions Article paywall
Polpharma Biologics gains FDA and EMA review acceptances PharmaTimes 15h FDA Inflammatory Bowel Disease
Ezplaz freeze-dried plasma receives FDA approval for transfusion Renal and Urology News 16h FDA Science
AstraZeneca and Bristol-Myers Squibb: Megamerger reports leave us scratching our heads MorningStar.com 16h Bristol Myers Squibb AstraZeneca
